Oviductal isthmic motility in relation to ovulation and endocrine changes in unrestrained sows.
This study was designed to characterize changes in the motility of the oviductal isthmus in relation to endocrine changes around ovulation in unrestrained sows in their normal environment. Oviductal isthmic motility was monitored on Polyview from 11 h prior to and up to 36 h after ovulation in 13 unrestrained multiparous sows during their second estrus after weaning, using a pressure microtransducer implanted 3 cm into the isthmus. Both the maximum, minimum and mean pressures and the frequency of phasic pressure fluctuations were high prior to ovulation but declined significantly (P<0.05) at 9 to 12 h, 13 to 16 h, 13 to 16 h and 5 to 8 h after ovulation, respectively. Plasma estradiol-17beta and prostaglandin F2alpha metabolite levels declined significantly (P<0.05) at 4 to 7 h prior to ovulation while progesterone levels increased significantly (P<0.01) at 5 to 8 h after ovulation. The decrease in the plasma estradiol-17beta levels was correlated to the decrease in maximum and mean pressures and the frequency of phasic pressure fluctuations (n=113; r=0.30, 0.25, 0.25, respectively; P<0.01) but not to the decrease in minimum pressure (n=113; r=0.17, P>0.05). Similarly, the decrease in PGF2alpha metabolite levels was correlated to the decrease in minimum, maximum and mean pressures and the frequency of phasic pressure fluctuations (n=112; r=0.43, 0.35, 0.38, 0.32, respectively; P<0.001). Conversely, the increase in plasma progesterone levels was correlated to the decrease in minimum, maximum and mean pressures and the frequency of phasic pressure fluctuations (n=113; r=-0.56, -0.70, -0.68, -0.60, respectively; P<0.001). Therefore, the pressure parameters seem to be influenced by changes in the levels of estradiol-17beta, prostaglandin F2alpha and progesterone with respect to ovulation.
Mwanza
A M
AM
Department of Obstetrics and Gynecology, Swedish University of Agricultural Sciences, Uppsala.
Lundeheim
N
N
Pettersson
A
A
Kindahl
H
H
Einarsson
S
S
D000818:Animals; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000097:blood; D004958:Estradiol / Q000097:blood*; D004972:Estrus Detection; D005187:Fallopian Tubes / Q000502:physiology*; D005260:Female; D007118:Immunoassay / Q000662:veterinary; D008297:Male; D009068:Movement; D010060:Ovulation / Q000502:physiology*; D011312:Pressure; D011374:Progesterone / Q000097:blood*; D011863:Radioimmunoassay / Q000662:veterinary; D012815:Signal Processing, Computer-Assisted; D018709:Statistics, Nonparametric; D013552:Swine / Q000502:physiology* / Q000601:surgery; D014160:Transducers, Pressure / Q000662:veterinary
C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D011374:Progesterone; D004958:Estradiol; D015237:Dinoprost